Search results for: 'research-area epigenetics parp'
- SRT2104 (GSK2245840)Catalog No. :A3821SIRT1 activator,selective
6-phenylimidazo[2,1-b]thiazole derivatives; sirtuin modulator.
- SRT1720 HClCatalog No. :A4180SIRT1 activator
SRT1720 is a small-molecule compound which has the ability of activating the sirtuin subtype SIRT1 in vitro.
- BMS 309403Catalog No. :B7794FABP4 inhibitor,potent and selective
Potent and selective adipocyte fatty acid binding protein 4 (aFABP4) inhibitor (Ki values are <2, 250 and 350 nM for aFABP4, mFABP4 and eFABP4 respectively). Decreases fatty acid uptake in adipocytes in vitro and reduces atherosclerotic lesion area in a mouse model of atherosclerosis. Reduces blood glucose levels and increases insulin sensitivity in a mouse model of obesity. Orally active.
- NicotinamideCatalog No. :N1651PARP-1 inhibitor
Nicomide Tablets for oral administration are peach-colored; oval-shaped tablets imprinted"Sirius" in blue ink on one Side.